Photo of Scott R. Plotkin, MD

Scott R. Plotkin, MD

  • Director, Neurofibromatosis Clinic
  • Director, MGH/DFCI/BWH Neuro-Oncology Fellowship Program

617-724-8770

Accepting New Patients

Overview

Departments

Neurology

Centers & Specialties

Cancer Center

MassGeneral Hospital for Children

Clinical Interests
  • Neurofibromatosis
  • Primary brain tumors
  • Brain and spinal cord tumors
  • Neurology
  • Pediatric Neurology
Medical Education
  • MD, PhD, Tulane University School of Medicine
  • Residency, Brigham and Women's Hospital
  • Fellowship, Massachusetts General Hospital
Board Certifications
  • Neurology
Locations
  • Boston: Massachusetts General Hospital
Existing Patients
Patient Gateway
Insurances Accepted
  • Aetna Health Inc.
  • AllWays Health (NHP) - ACD
  • AllWays Health (NHP) - PBO
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • BMC HealthNet Mass Health MCO/ACO
  • Cigna (PAL #'s)
  • Commonwealth Care Alliance
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • MassHealth
  • Medicare
  • Medicare - ACD
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Rhode Island
  • OSW - Vermont
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Railroad Medicare - ACD
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
  • Well Sense Pediatrics

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Patient Age Group
Adult and Pediatric
Provider Gender
Male

Research & Publications

Publications

View my most recent publications at PubMed

News & Events

  • Fundraising and fighting for a cure

    In 2012, when 30-year-old Quincy resident Alex Cellucci was nine months pregnant, she was diagnosed with neurofibromatosis, a genetic disorder that disturbs cell growth in the nervous system, enabling tumors to grow on any nerve in the body.

  • Treatment reverses hearing loss in patients with neurofibromatosis type 2

    Neurofibromatosis type 2 (NF2) is a genetic condition associated with bilateral vestibular schwannomas. It is rare, affecting only about one in 25,000 people.

  • Antiangiogenesis treatment improves hearing in some NF2 patients

    Treatment with the angiogenesis inhibitor bevacizumab improved hearing and alleviated other symptoms in patients with neurofibromatosis type 2 (NF2). The study by researchers from Massachusetts General Hospital (MGH) represents the first report of a successful NF2 treatment not involving surgery or radiation.

Contact

Pappas Center for Neuro Oncology
55 Fruit Street
Boston, MA 02114
Phone: 617-724-8770
Fax: 617-724-8769

Back to Top